False Claims Act Expertise
Thomas M. Greene recently testified before Congress on the False Claims Act, drawing on two decades of experience.
How to Choose an Attorney
What questions should you ask a False Claims Act attorney before making a decision?
About Greene llp
More about Greene LLP and its attorneys and their track record of perseverance and success.
Currently viewing the tag: "Derivative shareholder suits"

In response to a recent $600 million settlement with the Department of Justice, Allergan’s shareholders are now bringing a shareholder derivative lawsuit against the company. Stockholder Louisiana Municipal Police Employees Retirement System filed suit against Allergan executives, seeking to shift the burden of the settlement from Allergan to the [...]

Continue Reading

A federal district court judge has denied Pfizer’s motion to dismiss a derivative shareholder suit against the company which alleges that directors and executives at Pfizer are liable for actions that led to a historic $2.3 billion settlement with the U.S. government in 2009.  Pfizer entered into this enormous settlement to resolve allegations under the [...]

Continue Reading